These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2787123)

  • 21. Fluoxetine for depression.
    Med Lett Drugs Ther; 1988 Apr; 30(764):45-7. PubMed ID: 3258399
    [No Abstract]   [Full Text] [Related]  

  • 22. Fluoxetine treatment of obsessive compulsive disorder.
    Granet RB
    J Clin Psychiatry; 1989 Nov; 50(11):436. PubMed ID: 2808312
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder.
    Sayyah M; Boostani H; Pakseresht S; Malayeri A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):362-5. PubMed ID: 20035818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of fluoxetine-responsive psychogenic polydipsia: a variant of obsessive-compulsive disorder?
    Deas-Nesmith D; Brewerton TD
    J Nerv Ment Dis; 1992 May; 180(5):338-9. PubMed ID: 1583478
    [No Abstract]   [Full Text] [Related]  

  • 25. An open trial of buspirone in obsessive-compulsive disorder.
    Jenike MA; Baer L
    Am J Psychiatry; 1988 Oct; 145(10):1285-6. PubMed ID: 3048120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoxetine and obsessive-compulsive disorder: a naturalistic study.
    Wilcox JA
    J Psychoactive Drugs; 1990; 22(3):355-6. PubMed ID: 2286870
    [No Abstract]   [Full Text] [Related]  

  • 27. Buspirone augmentation of fluoxetine in a depressed child with obsessive-compulsive disorder.
    Alessi N; Bos T
    Am J Psychiatry; 1991 Nov; 148(11):1605-6. PubMed ID: 1928487
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
    Hollander E; DeCaria C; Gully R; Nitescu A; Suckow RF; Gorman JM; Klein DF; Liebowitz MR
    Psychiatry Res; 1991 Jan; 36(1):1-17. PubMed ID: 2017519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients.
    Hoehn-Saric R; Pearlson GD; Harris GJ; Machlin SR; Camargo EE
    Am J Psychiatry; 1991 Sep; 148(9):1243-5. PubMed ID: 1883007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postpartum obsessive compulsive disorder: a case series.
    Sichel DA; Cohen LS; Dimmock JA; Rosenbaum JF
    J Clin Psychiatry; 1993 Apr; 54(4):156-9. PubMed ID: 8486594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoxetine treatment of borderline mentally retarded adults with obsessive-compulsive disorder.
    Cook EH; Terry EJ; Heller W; Leventhal BL
    J Clin Psychopharmacol; 1990 Jun; 10(3):228-9. PubMed ID: 2376620
    [No Abstract]   [Full Text] [Related]  

  • 33. Familial obsessive-compulsive disorder presenting as pathological jealousy successfully treated with fluoxetine.
    Wright S
    Arch Gen Psychiatry; 1994 May; 51(5):430-1. PubMed ID: 8179468
    [No Abstract]   [Full Text] [Related]  

  • 34. Obsessive-compulsive disorder in HIV disease. Response to fluoxetine.
    McDaniel JS; Johnson KM
    Psychosomatics; 1995; 36(2):147-50. PubMed ID: 7724717
    [No Abstract]   [Full Text] [Related]  

  • 35. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder.
    Geller DA; Biederman J; Reed ED; Spencer T; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):36-44. PubMed ID: 7860454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder.
    Sayyah M; Boostani H; Pakseresht S; Malayeri A
    Psychiatry Res; 2011 Oct; 189(3):403-6. PubMed ID: 21329988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience.
    Riddle MA; Hardin MT; King R; Scahill L; Woolston JL
    J Am Acad Child Adolesc Psychiatry; 1990 Jan; 29(1):45-8. PubMed ID: 2295577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine in obsessive compulsive disorder in adolescents.
    Bouvard M; Dugas M
    Int Clin Psychopharmacol; 1993; 8(4):307-10. PubMed ID: 8277152
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacotherapy of obsessive compulsive disorder--experience with fluoxetine.
    Wood A; Tollefson GD; Birkett M
    Int Clin Psychopharmacol; 1993; 8(4):301-6. PubMed ID: 8277151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of drug treatment response in obsessive-compulsive disorder.
    Ravizza L; Barzega G; Bellino S; Bogetto F; Maina G
    J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.